Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase-Reference-Cited by-同舟云学术

Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase

Published:2003-08-20 Issue:5 Volume:98 Page:888-893
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

O'Brien Susan,Giles Francis,Talpaz Moshe,Cortes Jorge,Rios Mary Beth,Shan Jianqin,Thomas Deborah,Andreeff Michael,Kornblau Steven,Faderl Stefan,Garcia-Manero Guillermo,White Kevin,Mallard Susie,Freireich Emil,Kantarjian Hagop M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

2. Chronic Myelogenous Leukemia: Biology and Therapy

3. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]

4. Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications;European Journal of Medical Research;2024-05-04

2. High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial;Frontiers in Oncology;2022-12-08

3. High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study;Blood Cancer Journal;2022-10-28

4. Phytotherapeutics in cancer invasion and metastasis;Phytotherapy Research;2018-04-19

5. A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected;Oncology and Therapy;2018-03-15